1. Home
  2. TASK vs CRVS Comparison

TASK vs CRVS Comparison

Compare TASK & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TASK

TaskUs Inc.

N/A

Current Price

$8.73

Market Cap

755.5M

Sector

Technology

ML Signal

N/A

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

N/A

Current Price

$9.65

Market Cap

843.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TASK
CRVS
Founded
2008
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
755.5M
843.7M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
TASK
CRVS
Price
$8.73
$9.65
Analyst Decision
Hold
Strong Buy
Analyst Count
8
6
Target Price
$9.17
★ $31.50
AVG Volume (30 Days)
228.6K
★ 848.0K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 120.00
48.04
EPS
★ 0.78
N/A
Revenue
N/A
N/A
Revenue This Year
$5.65
N/A
Revenue Next Year
$5.86
N/A
P/E Ratio
$11.15
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.47
$6.39
52 Week High
$12.65
$26.95

Technical Indicators

Market Signals
Indicator
TASK
CRVS
Relative Strength Index (RSI) 49.76 39.68
Support Level $7.70 $9.40
Resistance Level $8.83 $10.81
Average True Range (ATR) 0.35 0.71
MACD -0.05 -0.04
Stochastic Oscillator 33.37 4.28

Price Performance

Historical Comparison
TASK
CRVS

About TASK TaskUs Inc.

TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: